Clinical trial
Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following…
NCT00234182 · The University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00234182 |
|---|---|
| Title | Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC |
| Official title | Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of Hepatocellular Carcinoma: a Randomized Controlled Trial |
| Lead sponsor | The University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Drug |
| Interventions | Interferon alpha-2b |
| Enrollment | 84 |
| Start date | Jan 1, 2000 |
| Completion | Dec 1, 2004 |
| First posted | Oct 6, 2005 |
| Last update posted | Dec 1, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: